All Companies
LLY
Eli Lilly & Co.Pharmaceutical Preparations
$1,152.93updated Sep 19, 2026
Congressional trading profile for Eli Lilly & Co. (LLY), covering 53 disclosed transactions by 22 lawmakers.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Total Trades
53
Politicians Trading
22
Last Traded
Jul 10, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Julie JohnsonD | Jan 15, 2026 | Dec 18, 2025 | Sell | $1,001 - $15,000 | +9.09% |
| Julie JohnsonD | Dec 11, 2025 | Nov 13, 2025 | Sell | $1,001 - $15,000 | +12.72% |
| Val T. HoyleD | Oct 10, 2025 | Sep 23, 2025 | Sell | $1,001 - $15,000 | +54.35% |
| Val T. HoyleD | Sep 12, 2025 | May 6, 2025 | Sell | $1,001 - $15,000 | +48.74% |
| Julie JohnsonD | Sep 11, 2025 | Aug 14, 2025 | Sell | $1,001 - $15,000 | +68.45% |
| Jonathan L. JacksonD | Aug 25, 2025 | May 21, 2025 | Sell | $1,001 - $15,000 | +59.04% |
| Jonathan L. JacksonD | Jul 14, 2025 | Jun 3, 2025 | Sell | $15,001 - $50,000 | +53.56% |
| Josh GottheimerD | Jun 11, 2025 | May 13, 2025 | Sell | $1,001 - $15,000 | +54.54% |
| Gilbert Ray Cisneros, Jr.D | Jun 6, 2025 | May 30, 2025 | Sell | $1,001 - $15,000 | +56.29% |
| Josh GottheimerD | May 14, 2025 | Apr 9, 2025 | Sell | $1,001 - $15,000 | +52.97% |
| Julie JohnsonD | May 14, 2025 | Apr 7, 2025 | Sell | $1,001 - $15,000 | +59.30% |
| Josh GottheimerD | Apr 10, 2025 | Mar 10, 2025 | Sell | $1,001 - $15,000 | +38.95% |
| Josh GottheimerD | Mar 6, 2025 | Feb 19, 2025 | Sell | $1,001 - $15,000 | +32.97% |
| Ron WydenD | Feb 21, 2025 | Feb 10, 2025 | Sell | $50,001 - $100,000 | +32.69% |
| Josh GottheimerD | Feb 10, 2025 | Jan 8, 2025 | Sell | $1,001 - $15,000 | +46.46% |